NDC 0078-1007-68
KESIMPTA 20 mg/.4mL
ofatumumab · INJECTION, SOLUTION
KESIMPTA is a injection, solution containing ofatumumab at a strength of 20 mg/.4mL. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- KESIMPTA
- Generic Name
- ofatumumab
- NDC Code (Package)
0078-1007-68- NDC Code (Product)
0078-1007- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 20 mg/.4mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125326
- Drug Class
- CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 10/26/2009
Recall History
No Recall HistoryView Full Drug Page
KESIMPTA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.